Association between metallic implants and stroke in US adults from NHANES 2015-2023 a cross-sectional study
- PMID: 39759400
- PMCID: PMC11695404
- DOI: 10.3389/fnagi.2024.1505645
Association between metallic implants and stroke in US adults from NHANES 2015-2023 a cross-sectional study
Abstract
Objective: Metal implants play a vital role in orthopedic treatment and are widely used in fracture repair, joint replacement and spinal surgery. Although these implants often contain key elements such as chromium (Cr), their potential health effects, particularly their association with stroke risk, have not been fully elucidated. This study aimed to evaluate the association between metallic implants and stroke.
Methods: Using data from the 2015 to 2023 National Health and Nutrition Examination Survey (NHANES), we conducted a cross-sectional analysis of 12,337 US adults, in which 3,699 participants reported having metal implants and 8,638 without. Implant-like.
Results: Through logistic regression analysis, we revealed a significant positive association between metallic implants and stroke risk (adjusted OR = 1.458, 95%CI (1.130, 1.881), p = 0.004). Further stratified analysis found that this positive association was more significant among older and less physically active participants.
Conclusion: Findings suggest that metallic implants may be associated with an increased risk of stroke, but given the inherent limitations of cross-sectional studies, this study cannot establish causality.
Keywords: NHANES; cross-sectional study; metal implants; risk factors; stroke.
Copyright © 2024 Wu, Pang, Su and Lv.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Comment in
-
Commentary: Association between metallic implants and stroke in US adults from NHANES 2015-2023 a cross-sectional study.Front Aging Neurosci. 2025 May 21;17:1586693. doi: 10.3389/fnagi.2025.1586693. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40469845 Free PMC article. No abstract available.
References
-
- Braakhuis H. M., Gosens I., Heringa M. B., Oomen A. G., Vandebriel R. J., Groenewold M., et al. (2021). Mechanism of action of TiO(2): recommendations to reduce uncertainties related to carcinogenic potential. Annu. Rev. Pharmacol. 61, 203–223. doi: 10.1146/annurev-pharmtox-101419-100049, PMID: - DOI - PubMed
LinkOut - more resources
Full Text Sources
